Ole Andreas Halvorsen - Viking Global Investors 13F Activity & Position Changes (Q4 2022)
As of Dec 31, 2022, the Viking Global Investors portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 14, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q4 2022, the filing reported:
New Buys - American International Group, I, Albemarle Corporation, Advanced Micro Devices, Inc., Brookfield Corporation, Capri Holdings, and 8 more
Increases - Acadia Healthcare Company, Inc., Amazon.com, Inc., KE Holdings Inc, BioMarin Pharmaceutical Inc., Cadence Design Systems, Inc., and 13 more
Reductions - Amylyx Pharmaceuticals, Inc., Ameriprise Financial, Inc., Boston Scientific Corporation, Chubb Limited, Charles River Laboratories Inte, and 21 more
Complete Exits - Apellis Pharmaceuticals, Inc., Avantor, Inc., Alibaba Group Holding Limited, Brookfield Asset Management Ltd., CBRE Group Inc, and 18 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q4 2022
|
ACHC
Acadia Healthcare Company, Inc.
|
Buy |
+202,182
|
|
Q4 2022
|
AIG
American International Group, I
|
Buy - Position Entry |
+2,590,026
|
|
Q4 2022
|
ALB
Albemarle Corporation
|
Buy - Position Entry |
+337,339
|
|
Q4 2022
|
AMD
Advanced Micro Devices, Inc.
|
Buy - Position Entry |
+1,905,600
|
|
Q4 2022
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
Sell |
-1,135,930
|
|
Q4 2022
|
AMP
Ameriprise Financial, Inc.
|
Sell |
-156,134
|
|
Q4 2022
|
AMZN
Amazon.com, Inc.
|
Buy |
+3,195,002
|
|
Q4 2022
|
APLS
Apellis Pharmaceuticals, Inc.
|
Sell - Position Exit |
-932,441
|
|
Q4 2022
|
AVTR
Avantor, Inc.
|
Sell - Position Exit |
-2,898,662
|
|
Q4 2022
|
BABA
Alibaba Group Holding Limited
|
Sell - Position Exit |
-1,246,400
|
|
Q4 2022
|
BAM
Brookfield Asset Management Ltd.
|
Sell - Position Exit |
-14,757,027
|
|
Q4 2022
|
BEKE
KE Holdings Inc
|
Buy |
+4,189,334
|
|
Q4 2022
|
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
+174,456
|
|
Q4 2022
|
BN
Brookfield Corporation
|
Buy - Position Entry |
+7,262,078
|
|
Q4 2022
|
BSX
Boston Scientific Corporation
|
Sell |
-6,634,328
|
|
Q4 2022
|
CB
Chubb Limited
|
Sell |
-13,114
|
|
Q4 2022
|
CBRE
CBRE Group Inc
|
Sell - Position Exit |
-409,714
|
|
Q4 2022
|
CDNS
Cadence Design Systems, Inc.
|
Buy |
+528,762
|
|
Q4 2022
|
CLX
Clorox Company (The)
|
Buy |
+162,184
|
|
Q4 2022
|
CME
CME Group Inc.
|
Sell - Position Exit |
-831,110
|
|
Q4 2022
|
CPRI
Capri Holdings
|
Buy - Position Entry |
+810,479
|
|
Q4 2022
|
CRL
Charles River Laboratories Inte
|
Sell |
-143,310
|
|
Q4 2022
|
CRM
Salesforce, Inc.
|
Sell - Position Exit |
-2,400,649
|
|
Q4 2022
|
CRWD
CrowdStrike Holdings, Inc.
|
Buy |
+415,619
|
|
Q4 2022
|
CSX
CSX Corporation
|
Buy - Position Entry |
+15,548,123
|
|
Q4 2022
|
CTLT
Catalent, Inc.
|
Sell |
-249,367
|
|
Q4 2022
|
DG
Dollar General Corporation
|
Sell |
-2,115,520
|
|
Q4 2022
|
DPZ
Domino's Pizza Inc
|
Sell - Position Exit |
-74,968
|
|
Q4 2022
|
ELV
Elevance Health, Inc.
|
Sell |
-464,665
|
|
Q4 2022
|
EQH
Equitable Holdings, Inc.
|
Buy - Position Entry |
+5,212,460
|
Page 1 of 3